Page 44 – ORTHOWORLD

Spine BioPharma Completes Enrollment for Phase III Clinical Trial

The trial is evaluating SB-01, the first intradiscal pharmacologic treatment to enter Phase III studies for the treatment of chronic...

Sep 24, 2024, Julie A. Vetalice

The patent covers the application of the company’s hydraulically powered distractor for use in corpectomy procedures....

Sep 24, 2024, Julie A. Vetalice

The SIGNUS ST structure features an open, macroporous titanium design resembling natural cancellous bone architecture....

Sep 23, 2024, Julie A. Vetalice

The CINA-CSpine algorithm enables detection and triage of cervical spine fractures. ...

Sep 20, 2024, Julie A. Vetalice

The integration brings offerings for joint replacement, spine, trauma, sports medicine, robotics and more....

Sep 20, 2024, Julie A. Vetalice

Consolidation, enabling technology and implant breakthroughs are creating long term change in the spine market....

Sep 19, 2024, Mike Evers

CATALYSTEM Primary Hip employs proprietary, patent-pending ACCUBROACH◊ Technology to deliver reproducibility between broach and implant....

Sep 18, 2024, Julie A. Vetalice

The line is compatible with the full range of Nexxt Spine cervical implants including NEXXT MATRIXX 3-D Printed implants, Cervical...

Sep 18, 2024, Julie A. Vetalice

Biocomposites acquired the remaining shares in Laboratorios SL and Synergie Ingénierie Médicale, gaining full control of the SYNICEM and Subiton...

Sep 18, 2024, Julie A. Vetalice

In part, funds will support enhanced capabilities of the AI-driven augmented reality intraoperative data platform, ADVISE....

Sep 17, 2024, Julie A. Vetalice